Richard T. Burke Sells 2,500 Shares of UnitedHealth Group Incorporated (NYSE:UNH) Stock

UnitedHealth Group Incorporated (NYSE:UNH) Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction dated Friday, September 17th. The stock was sold at an average price of $419.00, for a total transaction of $1,047,500.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Shares of NYSE:UNH opened at $408.70 on Thursday. The stock has a market capitalization of $385.37 billion, a price-to-earnings ratio of 26.99, a PEG ratio of 1.62 and a beta of 0.77. UnitedHealth Group Incorporated has a 1-year low of $289.64 and a 1-year high of $431.36. The company has a 50 day moving average price of $416.26 and a 200 day moving average price of $401.13. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.77 and a current ratio of 0.77.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Wednesday, July 14th. The healthcare conglomerate reported $4.70 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.43 by $0.27. UnitedHealth Group had a return on equity of 22.15% and a net margin of 5.33%. The business had revenue of $71.32 billion for the quarter, compared to analysts’ expectations of $69.51 billion. During the same period in the previous year, the firm posted $7.12 EPS. The company’s quarterly revenue was up 14.8% on a year-over-year basis. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 18.74 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 21st. Shareholders of record on Monday, September 13th were issued a $1.45 dividend. This represents a $5.80 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend was Friday, September 10th. UnitedHealth Group’s payout ratio is 34.36%.

UNH has been the subject of a number of analyst reports. Bank of America boosted their price objective on UnitedHealth Group from $450.00 to $522.00 and gave the company a “buy” rating in a research report on Tuesday, June 1st. Barclays upped their price target on shares of UnitedHealth Group from $435.00 to $465.00 and gave the stock an “overweight” rating in a research report on Friday, July 16th. Stephens upped their target price on shares of UnitedHealth Group from $440.00 to $460.00 and gave the stock an “overweight” rating in a research report on Friday, July 16th. Seaport Global Securities began coverage on UnitedHealth Group in a report on Friday, July 9th. They set a “buy” rating and a $450.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $418.00 to $421.00 and gave the stock a “buy” rating in a report on Tuesday, July 13th. Three analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $444.04.

Hedge funds have recently added to or reduced their stakes in the company. OLD Mission Capital LLC purchased a new position in UnitedHealth Group during the third quarter valued at approximately $439,000. Camden National Bank increased its stake in shares of UnitedHealth Group by 5.5% in the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock worth $667,000 after acquiring an additional 100 shares during the last quarter. Thompson Siegel & Walmsley LLC raised its holdings in shares of UnitedHealth Group by 1.3% during the first quarter. Thompson Siegel & Walmsley LLC now owns 2,110 shares of the healthcare conglomerate’s stock worth $785,000 after acquiring an additional 27 shares in the last quarter. D.A. Davidson & CO. grew its stake in UnitedHealth Group by 98.4% in the first quarter. D.A. Davidson & CO. now owns 32,836 shares of the healthcare conglomerate’s stock valued at $12,218,000 after purchasing an additional 16,282 shares in the last quarter. Finally, Kingfisher Capital LLC raised its stake in shares of UnitedHealth Group by 8.8% during the 1st quarter. Kingfisher Capital LLC now owns 1,079 shares of the healthcare conglomerate’s stock worth $401,000 after purchasing an additional 87 shares in the last quarter. Institutional investors and hedge funds own 86.21% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Recommended Story: Why is the ex-dividend date different from the record date?

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.